iguratimod has been researched along with 1-anilino-8-naphthalenesulfonate in 1 studies
| Studies (iguratimod) | Trials (iguratimod) | Recent Studies (post-2010) (iguratimod) | Studies (1-anilino-8-naphthalenesulfonate) | Trials (1-anilino-8-naphthalenesulfonate) | Recent Studies (post-2010) (1-anilino-8-naphthalenesulfonate) |
|---|---|---|---|---|---|
| 134 | 19 | 109 | 24,275 | 480 | 7,815 |
| Protein | Taxonomy | iguratimod (IC50) | 1-anilino-8-naphthalenesulfonate (IC50) |
|---|---|---|---|
| Chain A, RNA-directed RNA polymerase NS5 | Dengue virus 2 16681-PDK53 | 100 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 1.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, C; Huang, D; Li, Q; Miao, Y; Peng, Y; Shi, C; Zhu, X | 1 |
1 other study(ies) available for iguratimod and 1-anilino-8-naphthalenesulfonate
| Article | Year |
|---|---|
Iguratimod (T-614) attenuates severe acute pancreatitis by inhibiting the NLRP3 inflammasome and NF-κB pathway.
Topics: Acute Disease; Amylases; Animals; Chromones; Cyclooxygenase 2; Cytokines; Inflammasomes; Inflammation Mediators; Lipase; Male; Mice, Inbred C57BL; Neutrophil Infiltration; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Pancreas; Pancreatitis; Signal Transduction; Sulfonamides | 2019 |